Qaralink SA

Located in Switzerland, QARAlink specializes in providing a compliance management platform tailored for the MedTech industry, enhancing regulatory navigation for medical manufacturers through innovative solutions. QARAlink was founded in 2024 and is headquartered in Switzerland. The company focuses on delivering a compliance management platform specifically designed for the MedTech industry. It has completed one deal, raising a total of USD 0.

936 mn in its latest funding round in August 2025. The firm is led by a founder with a history of establishing other ventures. QARAlink primarily offers a compliance management platform tailored specifically for the MedTech industry. This platform provides a streamlined approach to navigating complex regulatory landscapes, allowing manufacturers to bring innovative medical solutions to market more efficiently.

Key features include real-time updates, customizable compliance tools, and step-by-step guidance, which help users manage their regulatory journeys with clarity and confidence. The platform accommodates a range of users from small startups to established medical device manufacturers, focusing on markets in Europe, North America, and Asia. QARAlink’s clients benefit from enhanced operational efficiency and reduced time spent on regulatory compliance, ultimately allowing them to focus more on product development and patient care. The revenue structure of QARAlink is built around a subscription-based model, where clients pay for access to the compliance platform based on tiered pricing plans that cater to various organizational needs.

This structure allows for scalability, as companies can choose a plan that aligns with their size and regulatory requirements. Transactions typically involve annual or monthly fees for platform access, with potential additional costs for advanced features or premium support services. The firm’s flagship offerings include tools that simplify submission processes and provide actionable insights into evolving regulations, which are vital for MedTech manufacturers looking to maintain compliance in a rapidly changing environment. QARAlink's business model emphasizes B2B relationships, directly serving manufacturers and regulatory professionals within the healthcare sector.

In August 2025, QARAlink raised USD 936,000 in pre-seed funding from individual and other unspecified investors. The company will use the funding to support its expansion plans and growth initiatives. Future product developments are underway to enhance the compliance platform further, with aims to launch these new features by the end of 2026. Additionally, QARAlink plans to expand into new markets including Asia and South America by 2027, aiming to meet the growing demand for regulatory solutions in these regions.